Actively Recruiting
SCAPIS 2 Spectrum Study Evaluating Microvascular Dysfunction in Adults Aged 60-75 at High Risk for Cardiovascular Disease
Led by HJN Sverige AB/Neko Health · Updated on 2026-01-22
900
Participants Needed
1
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating microvascular dysfunction, especially endothelial dysfunction, as a key factor in various cardiovascular diseases such as heart failure, ischemic heart disease, stroke, dementia, and kidney failure. This observational study focuses on adults aged 60 to 75 years at high risk of cardiovascular disease. The goal is to better understand how chronic low-grade inflammation linked to metabolic syndrome contributes to microvascular impairment and to enable early detection of these changes through non-invasive methods. Participants are divided into five groups based on specific heart conditions or metabolic health obstructive coronary artery disease O-CAD, angina with nonobstructive coronary arteries ANOCA, metabolic syndrome with diabetes, left ventricular systolic dysfunction, and left ventricular diastolic dysfunction. Each group has defined entry criteria. The study uses investigational devices to assess skin microvascular function, including Perimed Periflux EPOS, PeriCam MultiFlow, and TCI P4. Cardiac-specific assessment is performed with stress cardiac magnetic resonance imaging stress-CMR involving adenosine infusion and contrast to analyze myocardial blood flow. Participants will undergo comprehensive evaluations including skin perfusion measurements, dynamic microvascular response tests, and cardiac imaging. The study examines correlations between skin microcirculation, coronary artery disease severity, cardiac function markers, and biomarkers related to inflammation and metabolic health. Data collection occurs at baseline and includes follow-up visits within three months for some measurements. The total duration of participation depends on the timing of these assessments and imaging procedures.
CONDITIONS
Brief Title
Non-invasive Microvascular Assessment in Individuals at High Risk of Cardiovascular Disease From the SCAPIS2 Study
Research Team
M
Mattias Windå, Chief Science and Innovation Officer
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here